Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marco

Showing results (91-100 of 217) with videos related to

Pageof 22
Sort By:
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Radiology|September 3, 2024
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal CancerHannah Williams, Dana M Omer, Hannah M Thompson, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 18, 2008
Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorderH Christiansen, W Chen, R D Oades, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 3, 2008
No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorderX Xu, E A Duman, E Aysimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
ESMO Open|June 19, 2021
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078]G L Banna, A Cortellini, D L Cortinovis, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Pageof 22

Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Radiology|September 3, 2024
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal CancerHannah Williams, Dana M Omer, Hannah M Thompson, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 18, 2008
Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorderH Christiansen, W Chen, R D Oades, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 3, 2008
No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorderX Xu, E A Duman, E Aysimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
ESMO Open|June 19, 2021
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078]G L Banna, A Cortellini, D L Cortinovis, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Pageof 22